BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21325600)

  • 1. Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia/lymphoma.
    Sawada Y; Hino R; Hama K; Ohmori S; Fueki H; Yamada S; Fukamachi S; Tajiri M; Kubo R; Yoshioka M; Nakashima D; Sugita K; Yoshiki R; Shimauchi T; Mori T; Izu K; Kobayashi M; Nakamura M; Tokura Y
    Blood; 2011 Apr; 117(15):3961-7. PubMed ID: 21325600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin manifestations of adult T-cell leukemia/lymphoma: clinical, cytological and immunological features.
    Tokura Y; Sawada Y; Shimauchi T
    J Dermatol; 2014 Jan; 41(1):19-25. PubMed ID: 24438140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective study.
    Marchetti MA; Pulitzer MP; Myskowski PL; Dusza SW; Lunning MA; Horwitz SM; Moskowitz AJ; Querfeld C
    J Am Acad Dermatol; 2015 Feb; 72(2):293-301. PubMed ID: 25455841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meeting report on the possible proposal of an extranodal primary cutaneous variant in the lymphoma type of adult T-cell leukemia-lymphoma.
    Tsukasaki K; Imaizumi Y; Tokura Y; Ohshima K; Kawai K; Utsunomiya A; Amano M; Watanabe T; Nakamura S; Iwatsuki K; Kamihira S; Yamaguchi K; Shimoyama M
    J Dermatol; 2014 Jan; 41(1):26-8. PubMed ID: 24438141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and histopathological significance of PD-1 expression in cutaneous lesions of adult T-cell leukemia-lymphoma.
    Higuchi M; Kuwatsuka Y; Murota H; Iwanaga M; Niino D
    Pathol Res Pract; 2019 Jan; 215(1):40-49. PubMed ID: 30385085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous presentation of adult T-cell leukemia/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016.
    Hurabielle C; Battistella M; Ram-Wolff C; Fite C; Meignin V; Rivet J; Vignon-Pennamen MD; de Risi-Pugliese T; Raffoux E; Arnulf B; Oksenhendler E; Sicre de Fontbrune F; Peffault de Latour R; Socié G; Bouaziz JD; Lebbé C; Bensussan A; Bagot M
    Ann Dermatol Venereol; 2018; 145(6-7):405-412. PubMed ID: 29661476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival for skin-primary presentation of adult T-cell leukemia/lymphoma (ATLL).
    Jain M; Goyal K; O'Leary D; Rubin N; Bohjanen K; Goyal A
    J Am Acad Dermatol; 2020 Jul; 83(1):234-237. PubMed ID: 31765683
    [No Abstract]   [Full Text] [Related]  

  • 9. High Expression of Intestinal Homing Receptor CD103 in Adult T-Cell Leukemia/Lymphoma, Similar to 2 Other CD8+ T-Cell Lymphomas.
    Ishibashi H; Nimura S; Ishitsuka K; Mihashi Y; Mizoguchi M; Nakamura S; Okamura S; Momosaki S; Aoyagi K; Sakisaka S; Takeshita M
    Am J Surg Pathol; 2016 Apr; 40(4):462-70. PubMed ID: 26813744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
    Scarisbrick JJ; Kim YH; Whittaker SJ; Wood GS; Vermeer MH; Prince HM; Quaglino P
    Br J Dermatol; 2014 Jun; 170(6):1226-36. PubMed ID: 24641480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult T-cell leukemia/lymphoma and cutaneous T-cell lymphoma. Are they related?
    Yamada M; Takigawa M; Iwatsuki K; Inoue F
    Int J Dermatol; 1989 Mar; 28(2):107-13. PubMed ID: 2786860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of skin infiltrating cells in adult T-cell leukaemia/lymphoma (ATLL): clinical, histological and immunohistochemical studies on eight cases.
    Maeda K; Takahashi M
    Br J Dermatol; 1989 Nov; 121(5):603-12. PubMed ID: 2597633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the Sézary syndrome).
    Jones GW; Rosenthal D; Wilson LD
    Cancer; 1999 May; 85(9):1985-95. PubMed ID: 10223240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of the clinical classification of adult T-cell leukemia/lymphoma (ATLL) in the prognosis.
    Oliveira PD; Ribeiro GS; Anjos RO; Dias MA; Farre L; Araújo I; Bittencourt AL
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010807. PubMed ID: 36260617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
    Kim YH; Bishop K; Varghese A; Hoppe RT
    Arch Dermatol; 1995 Sep; 131(9):1003-8. PubMed ID: 7661601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [T-cell lymphoma of the skin--clinicopathological relationships, therapy and survival].
    Nagatani T; Kin S; Baba N; Miyamoto H; Nakajima H
    Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(5):579-91. PubMed ID: 2585773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous manifestations of adult T-cell leukemia/lymphoma.
    Miyashiro D; Sanches JA
    Semin Diagn Pathol; 2020 Mar; 37(2):81-91. PubMed ID: 31387753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic analysis of smoldering ATLL with skin eruptions based on genomic aberrations.
    Mochida K; Nakahata S; Suzuki Y; Inoue K; Moriguchi S; Yamashita A; Amano M; Morishita K
    J Dermatol Sci; 2023 Feb; 109(2):80-88. PubMed ID: 36842846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.
    Quaglino P; Pimpinelli N; Berti E; Calzavara-Pinton P; Alfonso Lombardo G; Rupoli S; Alaibac M; Bottoni U; Carbone A; Fava P; Fimiani M; Mamusa AM; Titli S; Zinzani PL; Bernengo MG;
    Cancer; 2012 Dec; 118(23):5830-9. PubMed ID: 22674564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.